Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Chris E. Talsness is active.

Publication


Featured researches published by Chris E. Talsness.


Philosophical Transactions of the Royal Society B | 2009

Components of plastic: experimental studies in animals and relevance for human health

Chris E. Talsness; Anderson J.M. Andrade; Sergio Noboru Kuriyama; Julia A. Taylor; Frederick S. vom Saal

Components used in plastics, such as phthalates, bisphenol A (BPA), polybrominated diphenyl ethers (PBDE) and tetrabromobisphenol A (TBBPA), are detected in humans. In addition to their utility in plastics, an inadvertent characteristic of these chemicals is the ability to alter the endocrine system. Phthalates function as anti-androgens while the main action attributed to BPA is oestrogen-like activity. PBDE and TBBPA have been shown to disrupt thyroid hormone homeostasis while PBDEs also exhibit anti-androgen action. Experimental investigations in animals indicate a wide variety of effects associated with exposure to these compounds, causing concern regarding potential risk to human health. For example, the spectrum of effects following perinatal exposure of male rats to phthalates has remarkable similarities to the testicular dysgenesis syndrome in humans. Concentrations of BPA in the foetal mouse within the range of unconjugated BPA levels observed in human foetal blood have produced effects in animal experiments. Finally, thyroid hormones are essential for normal neurological development and reproductive function. Human body burdens of these chemicals are detected with high prevalence, and concentrations in young children, a group particularly sensitive to exogenous insults, are typically higher, indicating the need to decrease exposure to these compounds.


Environmental Health Perspectives | 2009

Why public health agencies cannot depend on good laboratory practices as a criterion for selecting data: The case of Bisphenol A

John Peterson Myers; Frederick S. vom Saal; Benson T. Akingbemi; Koji Arizono; Scott M. Belcher; Theo Colborn; Ibrahim Chahoud; D. Andrew Crain; Francesca Farabollini; Louis J. Guillette; Terry Hassold; Shuk-Mei Ho; Patricia A. Hunt; Taisen Iguchi; Susan Jobling; Jun Kanno; Hans Laufer; Michele Marcus; John A. McLachlan; Angel Nadal; Jörg Oehlmann; Nicolás Olea; Paola Palanza; Stefano Parmigiani; Beverly S. Rubin; Gilbert Schoenfelder; Carlos Sonnenschein; Ana M. Soto; Chris E. Talsness; Julia A. Taylor

Background In their safety evaluations of bisphenol A (BPA), the U.S. Food and Drug Administration (FDA) and a counterpart in Europe, the European Food Safety Authority (EFSA), have given special prominence to two industry-funded studies that adhered to standards defined by Good Laboratory Practices (GLP). These same agencies have given much less weight in risk assessments to a large number of independently replicated non-GLP studies conducted with government funding by the leading experts in various fields of science from around the world. Objectives We reviewed differences between industry-funded GLP studies of BPA conducted by commercial laboratories for regulatory purposes and non-GLP studies conducted in academic and government laboratories to identify hazards and molecular mechanisms mediating adverse effects. We examined the methods and results in the GLP studies that were pivotal in the draft decision of the U.S. FDA declaring BPA safe in relation to findings from studies that were competitive for U.S. National Institutes of Health (NIH) funding, peer-reviewed for publication in leading journals, subject to independent replication, but rejected by the U.S. FDA for regulatory purposes. Discussion Although the U.S. FDA and EFSA have deemed two industry-funded GLP studies of BPA to be superior to hundreds of studies funded by the U.S. NIH and NIH counterparts in other countries, the GLP studies on which the agencies based their decisions have serious conceptual and methodologic flaws. In addition, the U.S. FDA and EFSA have mistakenly assumed that GLP yields valid and reliable scientific findings (i.e., “good science”). Their rationale for favoring GLP studies over hundreds of publically funded studies ignores the central factor in determining the reliability and validity of scientific findings, namely, independent replication, and use of the most appropriate and sensitive state-of-the-art assays, neither of which is an expectation of industry-funded GLP research. Conclusions Public health decisions should be based on studies using appropriate protocols with appropriate controls and the most sensitive assays, not GLP. Relevant NIH-funded research using state-of-the-art techniques should play a prominent role in safety evaluations of chemicals.


Toxicology | 2009

Sex differences in effects on sexual development in rat offspring after pre- and postnatal exposure to triphenyltin chloride.

Konstanze Grote; Carolin Hobler; Anderson J.M. Andrade; Simone Wichert Grande; Christine Gericke; Chris E. Talsness; Klaus E. Appel; Ibrahim Chahoud

Consumers are exposed to organotin compounds (OTCs) via contaminated fish and seafood due to the accumulation of these compounds in marine organisms. Certain OTCs are immunotoxic and may also have endocrine disrupting properties resulting in adverse effects on the reproductive tract in mollusks and mammals. Since effects of in utero exposure to endocrine disrupting chemicals on the reproductive system are dependent on the critical window of exposure during its development, we conducted a comprehensive study with the aim to identify the most sensitive window of exposure to TPTCl and to investigate the effects of pre- and postnatal treatment on sexual development in rats. Male and female offspring rats were exposed to 2 or 6 mg TPTCl/kg b.w. and day either in utero and during lactation (gestation day 6 until weaning on PND 21) or from gestation day 6 until termination. As previously reported, offspring in the 6 mg TPTCl dose group exhibited high perinatal mortality and therefore no further evaluation was carried out at this dose level (Grote, K., Hobler, C, Andrade, A.J.M., Wichert Grande, S., Gericke, C., Talsness, C.E., Appel, K.E., Chahoud, I., 2007. Effects of in utero and lactational exposure to triphenyltin chloride on pregnancy outcome and postnatal development in rat offspring. Toxicology 238, 177-185). In the present paper, results on postnatal development obtained from surviving offspring of dams exposed to 2mg TPTCl/kg b.w. are reported. Male offspring were sacrificed on PND 64 or 65 and female offspring at first estrus after PND 58. A clear sex difference in response to treatment was observed. Male postnatal development was severely affected with decreases in body weight gain, reproductive organ weights and testosterone concentration as well as a significant delay in the age at preputial separation. In contrast, females exhibited a precocious completion of vaginal opening while all other endpoints were unaffected. Most of these effects were already present in animals that were only exposed until weaning indicating that these effects may be irreversible and continued treatment until termination had contributed less than expected to the severity of the observed effects. The results of the present study suggest that the sensitive window for the evaluated endpoints seems to be the period of prenatal development and that male offspring rats were more susceptible to treatment.


Toxicology | 2009

Prenatal exposure to diesel exhaust particles and effect on the male reproductive system in mice.

Jette Gjerke Hemmingsen; Karin Sørig Hougaard; Chris E. Talsness; Anja Wellejus; Steffen Loft; Håkan Wallin; Peter Møller

In utero exposure to diesel exhaust particles may reduce sperm production in adulthood. We investigated the effect of prenatal exposure to diesel exhaust particles on the male reproductive system and assessed endocrine disruption and regulation of aquaporin expression as possible mechanisms of action. Dams inhaled 20 mg/m(3) of diesel exhaust particle standard reference material 2975 (SRM2975) or clean air for 1h/day on day 7-19 during pregnancy. Male offspring were killed on day 170 after birth. The dams that had inhaled SRM2975 delivered offspring, which in adulthood had reduced daily sperm production (P=0.046, Mann-Whitney U-test), whereas there were no differences in the body weight, testis weight and anogenital distance. There was no difference in plasma testosterone and estradiol concentrations, although some samples were not analyzed precisely because of technical problems. The gene regulation of the androgen receptor, anti-Müllerian hormone, estrogen receptor-alpha, estrogen receptor-beta, follicle-stimulating hormone receptor, insulin-like growth factor 3, luteinising hormone receptor, and aromatase in testes, were not significantly altered in the group exposed in utero to SRM2975 compared to controls. These data indicate that prenatal exposure to SRM2975 was not associated with endocrine disruptor activity in adulthood. There was no significant change in expression levels of aquaporins 7, 8 and 9 in testes tissue, measured as mRNA expression and protein levels by immunohistochemistry. In conclusion, prenatal exposure to SRM2975 was associated with reduced daily sperm production in adulthood, which was not possible to clearly associate with altered endocrine function or expression of aquaporins in the testes.


Toxicology | 2010

Sex-dependent aromatase activity in rat offspring after pre- and postnatal exposure to triphenyltin chloride

Carolin Hobler; Anderson J.M. Andrade; Simone Wichert Grande; Christine Gericke; Chris E. Talsness; Klaus E. Appel; Ibrahim Chahoud; Konstanze Grote

Triphenyltin (TPT) is an organotin compound (OTC) previously widely used as an antifouling agent in paints applied in the marine environment, a fungicide, and as an agricultural pesticide. In female aquatic invertebrates, certain OTCs induce the so-called imposex, an abnormal induction of male sex characteristics. OTC-induced environmental endocrine disruption also occurs in fish and mammals and a number of in vivo and in vitro studies have argued that OTCs may act through inhibition of the aromatase enzyme. In vivo studies supporting the aromatase inhibition hypothesis in mammals are lacking. Recently, the causal relationship between inhibition of aromatase and imposex was questioned, suggesting aromatase independent mechanisms of action for this phenomenon. We conducted a comprehensive investigation to identify the most sensitive window of exposure to TPTCl and to examine the effects of pre- and postnatal exposure on postnatal development in rats. The results on brain and gonadal aromatase activity obtained from offspring of dams exposed to 2 mg TPTCl/kg bw are reported here. Female and male offspring rats were exposed to 2 mg TPTCl/kg bw/d in utero from gestation day 6 through lactation until weaning on PND 21, or from gestation day 6 until termination at adulthood. Male offspring were sacrificed from PND 58 and female offspring at first estrus after PND 58. Pre- and postnatal TPT exposure clearly affected brain and gonadal aromatase activity in a sex-dependent fashion. While brain aromatase activity was significantly increased on PND 21 and at adulthood in female offspring, male offspring exhibited a significant decrease in brain aromatase activity only at adulthood. Ovarian aromatase activity was unaffected at both time points investigated. In contrast, testicular aromatase activity was significantly increased in males on PND 21 and significantly decreased at adulthood independent from the duration of treatment. The results of the present study confirm our previously reported observations regarding sex-dependent differences in sexual development after TPT exposure with the male rat being more susceptible to disturbances through this endocrine active compound than the female. We conclude that TPT administered during the particularly vulnerable period of development can affect aromatase activity in rats.


Reproductive Toxicology | 2015

Postnatal investigation of prenatally induced effects on the vertebral column of rats reduces the uncertainty of classification of anomalies

Ibrahim Chahoud; Chris E. Talsness; A. Walter; Konstanze Grote

Classification of substances as teratogenic is based on the observation of external, visceral and skeletal anomalies. Characterization of anomalies as variation or malformation is contingent upon their postnatal persistence and adversity to health. Lack of information thereof may result in inconsistent or incorrect classification. The aim of this work is the examination of vertebral skeletal anomalies regarding their postnatal fate on PNDs 7 and 21. The anomalies unossified, asymmetric ossification, bipartite ossification, hemicentric, as well as misshapen, did not persist up to PND21 and should be classified as a variation. The finding, cervical vertebra centrum dumbbell-shaped, should be categorized as a malformation due to its continued presence on PND 21. Lumbar centrum supernumerary sinister/dexter/sinister+dexter should also be classified as a malformation. This study demonstrates that postnatal examination is useful and substantially improves the ability to perform a scientifically sound classification of an anomaly compared to investigations terminated on GD 21.


Journal of Toxicology and Environmental Health | 2015

Prenatal exposure to the phytoestrogen daidzein resulted in persistent changes in ovarian surface epithelial cell height, folliculogenesis, and estrus phase length in adult Sprague-Dawley rat offspring.

Chris E. Talsness; Konstanze Grote; Sergio Noboru Kuriyama; Kenia Presibella; Anja Sterner-Kock; Katia Poça; Ibrahim Chahoud

Daidzein (DZ), an isoflavone with the potential to interfere with estrogen signaling, is found in soy products, which have gained popularity due to purported beneficial effects on the cardiovascular and skeletal systems and potential antineoplastic properties. However, the ingestion of phytoestrogens has been associated with impaired reproductive function in many species. The aim of this study was to determine the long-term effects on the ovaries of rat offspring exposed to DZ or ethinyl estradiol (EE) during prenatal development. Gravid rats were administered either vehicle or 5 or 60 mg DZ/kg body weight/d or 0.002 mg 17-α EE /kg body weight/d on gestational days 6–21. Ovarian-related endpoints were investigated during adulthood in female offspring. The mean cell height of the ovarian surface epithelium was significantly reduced in all treated groups. Alterations in folliculogenesis included increased follicular atresia, a reduction in secondary and tertiary follicle numbers, and cyst formation. An elevated prevalence of a slightly prolonged estrus phase was also observed. The morphological changes to the ovarian surface epithelium are consistent with an antiproliferative effect, while ovarian folliculogenesis was adversely affected. The effects of the high dose DZ were similar to those observed with 17-α EE.


Reproductive Toxicology | 2016

Response to Dr. Francisco Paumgartten's letter to the Editor: "On the persistence of rat axial skeleton anomalies after birth".

Ibrahim Chahoud; Chris E. Talsness; Alice Walter; Konstanze Grote

We welcome the contribution of Dr. Paumgartten to the debate n the classification of anomalies based on examination on GD 1 versus examination at different postnatal time points. This ery important unresolved topic was addressed more than three ecades ago by Khera [5] and one objective of our publication was he revival of the discussion regarding the postnatal fate of skeletal nomalies detected on GD 21. In his letter to the editor, Dr. Paumgartten refers to the missing ata on postnatal body weight gain and mortality in our study. In lassic developmental toxicity studies, one distinguishes between ffects on survival, growth and visceral or skeletal structures. The valuation of structural anomalies on GD 21, therefore, is carried ut independently from the number of resorptions or fetal moralities which may occur due to lethal structural anomalies. This ethodology may lead to an observed lower incidence of strucural anomalies in the affected embryos. However, we applied this lassical methodology to our present study in order to standardize he comparisons between GD 21 and the different PND time points. his was also the case in the study by Marr et al. [6]. We would also like to emphasize that the present study was not esigned to evaluate the embryotoxicity of FUDR. As stated in the ublication, FUDR is a known teratogen and we used it as a model ubstance. The aim of our study was to compare the classical time oint of observation on GD 21 to two postnatal time points, PND 7 nd PND 21, in order to evaluate the persistence of vertebral findngs. For the above mentioned reasons, the evaluation of postnatal ody weight gain and mortality were not objectives of the study s the incidence of anomalies is evaluated independent from these arameters on GD 21. Dr. Paumgartten states that it is not suitable to classify umbbell-shaped ossification centers as malformations due to their ersistence on PND 21. He bases his argument on the findings by arr et al., who no longer observed anomalies of vertebral centers f offspring evaluated on PND 63. We chose to evaluate postnatal ay 21 as it is considered to be an important time point in rodent evelopment and is a frequent time point of analysis in developental toxicity studies. Skeletal anomalies resolved by this time oint would presumably have less impact on human health and unction than ones which take a longer period of time. On PND 63, ost strains of rats have completed puberty and are transitioning nto adulthood. We consider anomalies still present on PND 21 to e relevant for human health and based on the data collected on ND 21 in our study, we have to suggest that their classification be s malformation.


Critical Reviews in Toxicology | 2005

Commentary on "Cancer biology and hormesis: human tumor cell lines commonly display hormetic (biphasic) dose responses" by Edward J. Calabrese.

Chris E. Talsness; Ibrahim Chahoud

The review article by E. J. Calabrese entitled “Cancer Biology and Hormesis: Human Tumor Cell Lines Commonly Display Hormetic (Biphasic) Dose Responses” represents a clear overview of in vitro dose-response relationships obtained by several investigators using a wide variety of cancer cell lines in reaction to agents spanning a great number of classes and types. The concepts he wishes to convey are supported by straightforward graphics, and the data taken from the literature along with each author’s respective interpretations are presented in table form, making them easily accessible to the reader. Comprehensive tables listing the agents and cell lines evaluated are also given. Possible mechanisms for the biphasic dose-response curves are presented, as well as sections addressing implications for experimental design and possible clinical ramifications. In previously published works, this author has undertaken exhaustive research of the literature from diverse fields analyzing dose-response curves and has reported that a biphasic dose-response relationship occurs more often than other doseresponse models. From these surveys, general characteristics of biphasic responses have been identified, and this integrative analysis evaluates whether these attributes are present in the dose-response relationships obtained with studies employing tumor cell lines. The author provides evidence that hormetic dose-response relationships characterized by low-dose stimulation and high-dose inhibition in these cell lines are common. Following examination of epidemiological literature, other authors have concluded that the occurrences of linear and nonlinear dose response relationships are about equally frequent.1 This article and others by Calabrese and colleagues question the foundation on which toxicological risk assessment is based. Human health risk assessment in the field of toxicology assumes that potential toxins or carcinogens behave according to a linear


Reproductive Toxicology | 2007

Chapel Hill bisphenol A expert panel consensus statement: Integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure

Frederick S. vom Saal; Benson T. Akingbemi; Scott M. Belcher; Linda S. Birnbaum; D. Andrew Crain; Marcus Eriksen; Francesca Farabollini; Louis J. Guillette; Russ Hauser; Jerrold J. Heindel; Shuk-Mei Ho; Patricia A. Hunt; Taisen Iguchi; Susan Jobling; Jun Kanno; Ruth A. Keri; Karen E. Knudsen; Hans Laufer; Gerald A. LeBlanc; Michele Marcus; John A. McLachlan; John Peterson Myers; Angel Nadal; Retha R. Newbold; Nicolás Olea; Gail S. Prins; Catherine A. Richter; Beverly S. Rubin; Carlos Sonnenschein; Ana M. Soto

Collaboration


Dive into the Chris E. Talsness's collaboration.

Top Co-Authors

Avatar

Klaus E. Appel

Federal Institute for Risk Assessment

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge